Annual Report And Accounts

Overview

The report describes Oxford BioDynamics' ahead-of-schedule launch of the EpiSwitch® PSE prostate screening test in the US and UK, alongside continued commercialization of its CiRT test. Group revenue rose to £0.51m as proprietary-test revenue became significant. Its sustainability disclosure applies the SASB Materiality Finder while acknowledging that ESG metrics remain at an early stage.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: Ends 30 September 2023
Publication date: 16 January 2024
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services